USE OF CMV HYPERIMMUNOGLOBULINS (CYTOTECT) AS PREEMPTIVE TREATMENT OF CMV INFECTION IN PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION - A SINGLE CENTRE EXPERIENCE

被引：0
|
作者：
Desnica, Lana [1 ]
Durakovic, Nadira [1 ]
Peric, Zinaida [1 ]
Serventi-Seiwerth, Ranka [1 ]
Roncevic, Pavle [1 ]
Sertic, Dubravka [1 ]
Mikulic, Mirta [1 ]
Pulanic, Drazen [1 ]
Vrhovac, Radovan [1 ]
机构：
[1] Univ Hosp Ctr Zagreb, Zagreb, Croatia
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P405
引用
收藏
页码：430 / 431
页数：2
相关论文
共 50 条
  • [41] Clinical Impact and Burden of CMV Infection on the Use of Resources in Allogeneic Hematopoietic Cell Transplantation
    de Miguel, Carlos
    Luis Cruz, Juan
    Francisca Portero, Maria
    Esther Martinez-Munoz, Maria
    Isabel Sanchez-Romero, Maria
    Bautista, Guiomar
    Cabrera, Rafael
    Duarte, Rafael F.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S388 - S388
  • [42] High incidence of CMV infection in adult T-cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation
    Nakano, N.
    Kubota, A.
    Tokunaga, M.
    Tokunaga, M.
    Itoyama, T.
    Makino, T.
    Takeuchi, S.
    Takatsuka, Y.
    Utsunomiya, A.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 (12) : 1548 - 1549
  • [43] High incidence of CMV infection in adult T-cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation
    N Nakano
    A Kubota
    M Tokunaga
    M Tokunaga
    T Itoyama
    T Makino
    S Takeuchi
    Y Takatsuka
    A Utsunomiya
    [J]. Bone Marrow Transplantation, 2014, 49 : 1548 - 1549
  • [44] Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience
    Gill, Jessica
    Stella, Davide
    Dogliotti, Irene
    Dellacasa, Chiara
    Giaccone, Luisa
    Busca, Alessandro
    [J]. HEMATO, 2023, 4 (02): : 158 - 169
  • [45] Incidence of CMV infection and CMV disease in allogeneic transplanted patients: From no prophylaxis to preemptive treatment.
    Meuleman, N
    Debruyne, JM
    Jacquy, C
    Bron, D
    [J]. BLOOD, 2000, 96 (11) : 341B - 341B
  • [46] Incidence of CMV Reactivation and Infection in Children and Adolescents Following Allogeneic Hematopoietic Stem Cell Transplantation in High CMV Exposure Population
    Hussein, Ayad Ahmed
    Al-Antary, Eman T.
    Al-Zaben, Abdulhadi I.
    Frangoul, Haydar A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S253 - S253
  • [47] Lymphotropic herpesvirus DNA detection in patients with active CMV infection - a possible role in the course of CMV infection after hematopoietic stem cell transplantation
    Zawilinska, Barbara
    Kopec, Jolanta
    Szostek, Slawa
    Piatkowska-Jakubas, Beata
    Skotnicki, Aleksander B.
    Kosz-Vnenchak, Magdalena
    [J]. MEDICAL SCIENCE MONITOR, 2011, 17 (08): : CR432 - CR441
  • [48] Pre-emptive therapy of CMV infection in allogeneic hematopoietic stem cell transplantation.
    Dentamaro, T
    Cudillo, L
    Picardi, A
    Postorino, M
    Gallone, D
    Masi, M
    Amadori, S
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S63 - S63
  • [49] Increased risk of complicated CMV infection after the use of mycophenolate mofetil in allogeneic stem cell transplantation
    Hambach, L
    Stadler, M
    Franzke, A
    Biersack, H
    Dammann, E
    Ganser, A
    Hertenstein, B
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S153 - S154
  • [50] Comparison of CMV antigenaemia and quantitative realtime PCR CMV-DNA assay in the detection of CMV infection in patients after allogeneic haematopoietic stem cell transplantation
    Gozdzik, J.
    Mordel, A.
    Lesko, E.
    Krasowska-Kwiecien, A.
    Kacinska, E.
    Wedrychowicz, A.
    Czogala, W.
    Wiecha, O.
    Skoczen, S.
    Majka, M.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S176 - S176
12345